Oncolytic Measles Viruses as Therapeutic Vectors for Tumor-Directed BiTE Expression

被引：0
|
作者：
Speck, Tobias [1 ]
Heidbuechel, Johannes [1 ]
Jaeger, Dirk [1 ]
von Kalle, Christof [1 ]
Ungerechts, Guy [1 ]
Engeland, Christine E. [1 ]
机构：
[1] Natl Ctr Tumor Dis, Heidelberg, Germany
来源：
MOLECULAR THERAPY | 2017年 / 25卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
9
引用
收藏
页码：5 / 5
页数：1
相关论文
共 33 条
  • [1] Oncolytic measles viruses as therapeutic vectors for targeted BiTE expression in solid tumours
    Speck, T.
    Heidbuechel, J.
    Veinalde, R.
    Jaeger, D.
    von Kalle, C.
    Ball, C. R.
    Ungerechts, G.
    Engeland, C. E.
    HUMAN GENE THERAPY, 2017, 28 (12) : A5 - A5
  • [2] Retargeted oncolytic viruses provoke tumor-directed T-cell responses
    Kloos, Arnold
    Woller, Norman
    Gerardy-Schahn, Rita
    Kuehnel, Florian
    ONCOIMMUNOLOGY, 2015, 4 (12):
  • [3] Tumor-Directed Therapeutic Targets in Cushing Disease
    Theodoropoulou, Marily
    Reincke, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (03): : 925 - 933
  • [4] In vivo antitumor activity by dual stromal and tumor-targeted oncolytic measles viruses
    Yuqi Jing
    Valery Chavez
    Natasha Khatwani
    Yuguang Ban
    Andrea P. Espejo
    Xi Chen
    Jaime R. Merchan
    Cancer Gene Therapy, 2020, 27 : 910 - 922
  • [5] Specific elimination of CD133+tumor cells with retargeted oncolytic measles viruses
    Abel, Tobias
    Bach, Patricia
    Hoffmann, Christopher
    Gal, Zoltan
    Braun, Gundula
    Voelker, Iris M.
    Ball, Claudia R.
    Johnston, Ian C. D.
    Lauer, Ulrich M.
    Herold-Mende, Christel
    Muehlebach, Michael D.
    Glimm, Hanno
    Buchholz, Christian J.
    HUMAN GENE THERAPY, 2012, 23 (10) : A90 - A91
  • [6] In vivo antitumor activity by dual stromal and tumor-targeted oncolytic measles viruses
    Jing, Yuqi
    Chavez, Valery
    Khatwani, Natasha
    Ban, Yuguang
    Espejo, Andrea P.
    Chen, Xi
    Merchan, Jaime R.
    CANCER GENE THERAPY, 2020, 27 (12) : 910 - 922
  • [7] Effective DARPin-targeted oncolytic measles viruses directed against HER2/neu, EGFR, or EpCAM expressing tumor cells
    Friedrich, K.
    Muench, R.
    Pruefer, S.
    Hanauer, J.
    Filippis, C.
    Jost, C.
    Cattaneo, R.
    Peng, K-W
    Plueckthun, A.
    Buchholz, C.
    Cichutek, K.
    Muehlebach, M.
    HUMAN GENE THERAPY, 2011, 22 (10) : A118 - A119
  • [8] Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses
    Weiland, Timo
    Lampe, Johanna
    Essmann, Frank
    Venturelli, Sascha
    Berger, Alexander
    Bossow, Sascha
    Berchtold, Susanne
    Schulze-Osthoff, Klaus
    Lauer, Ulrich M.
    Bitzer, Michael
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (01) : 235 - 243
  • [9] CARE AND BIOSAFETY CONSIDERATIONS FOR THE NOVEL TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPY RP1: A NOTE FROM A NURSING PERSPECTIVE
    Rohlfs, Michelle
    VanDaele, Teena
    Kaveney, Sarah
    Bommareddy, Praveen
    ONCOLOGY NURSING FORUM, 2024, 51 (02)
  • [10] Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
    Speck, Tobias
    Heidbuechel, Johannes P. W.
    Veinalde, Rueta
    Jaeger, Dirk
    von Kalle, Christof
    Ball, Claudia R.
    Ungerechts, Guy
    Engeland, Christine E.
    CLINICAL CANCER RESEARCH, 2018, 24 (09) : 2128 - 2137
1234